Work

On-Treatment Cancer Safety Events With Daprodustat vs. Erythropoiesis-Stimulating Agents: Post Hoc Analyses of ASCEND-ND and ASCEND-D

Year: 2022

Type: conference-abstract

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20223311s1631d

Authors: Ajay K. Singh, Finnian R. McCausland, Brian Claggett, Christoph Wanner, Andrzej Wiecek, Michael B. Atkins, Kevin Carroll, Vlado Perkovic, John McMurray, Janet Wittes, Steven M. Snapinn, Allison Blackorby, Tara Barker, Tara L. Dimino, Stephen Mallett, Amy M. Meadowcroft, Alexander R. Cobitz, Scott D. Solomon

Institutions: Brigham and Women's Hospital, Universitätsklinikum Würzburg, Medical University of Silesia, Georgetown Lombardi Comprehensive Cancer Center, The University of Sydney, University of Glasgow, Statistics Collaborative, GlaxoSmithKline (United States)

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396990237

Cites:

Cited by:

Related to: 10